IHS Chemical Week

EnviroTech :: Biotech

Novozymes’ First-Half Ebitda Rises 11% Despite Market Uncertainty

7:08 AM MDT | August 11, 2011 | Alex Scott

Novozymes, a biotech firm, says its Ebitda for the first half of the year increased 11% to DK1.6 billion ($306 million) on sales up 9% to DK5.3 billion. All expectations for full-year 2011 are maintained, the company says.   “l'm satisfied with the half-year results, and although we're seeing increasing general uncertainty concerning the global economic situation and increased volatility in our end markets, we’re able to maintain our sales and earnings growth guidance for the full year,” says Steen Riisgaard, president and CEO.   Sales...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa